| human | Q5 |
| P496 | ORCID iD | 0000-0003-2590-7218 |
| P1416 | affiliation | University of Pennsylvania Department of History | Q104051213 |
| P108 | employer | University of Pennsylvania | Q49117 |
| P735 | given name | Ann | Q558067 |
| Ann | Q558067 | ||
| P106 | occupation | researcher | Q1650915 |
| Q97418604 | Author Correction: Regulation of sister chromatid cohesion by nuclear PD-L1 |
| Q64121167 | Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update |
| Q47795034 | Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant |
| Q92397645 | Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol) |
| Q91706017 | Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare |
| Q96430886 | Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type |
| Q88511739 | DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine |
| Q98179887 | Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery |
| Q104469551 | Does Transfusion of Red Blood Cells Impact Germline Genetic Test Results? |
| Q47137308 | Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study |
| Q36025853 | Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy |
| Q38503290 | Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics |
| Q36798838 | Glutathione s-transferase p1: gene sequence variation and functional genomic studies |
| Q114015275 | Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study |
| Q94461827 | Regulation of sister chromatid cohesion by nuclear PD-L1 |
| Q35605304 | SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen |
| Q90669281 | Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics |
| Q92971607 | Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall |
| Q33614238 | Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer |
Search more.